The Billionaire CEO Uncovers His Newlywed Wife's Poisonous Plot to Seize His Empire and Eliminate His Housekeeper
The anonymous tip to Detective Harding was a calculated risk.
I had used a secure, untraceable burner phone and a voice modulator, ensuring no direct link back to me. The information I provided was specific, hinting at corporate malfeasance and a potential personal threat without revealing the full, unbelievable truth.
“A defunct biotech firm, CogniSolve Labs, primarily funded by a secretive investor, developed a designer neurotoxin capable of causing progressive cognitive decline,” I stated, my voice distorted. “The firm dissolved under suspicious circumstances.”
Harding, a seasoned veteran of white-collar crime, was known for his methodical approach. He wouldn’t jump to conclusions, especially from an anonymous source.
Two days later, the news hit. A small article in the local business section, easily overlooked by most.
“Detective Harding’s Task Force Investigates Dormant Biotech Firm’s Records.”
It was vague, non-committal, but it was enough. He was looking.
I received a coded message from a contact within the police department—a former cyber-security consultant I had helped out years ago. “Harding is interested. Your information on the firm and the ‘Compound X-7’ has piqued his curiosity.”
Piqued his curiosity was an understatement. I knew Harding. He would be digging.
The challenge was Harding’s natural skepticism. “Billionaire’s crazy wife” was a narrative he’d likely heard before. He needed hard, verifiable facts, not just a whispered conspiracy.
My information, though anonymous, was precisely detailed. I had given him the specific name of the neurotoxin, its alleged effects, and the defunct firm’s name. Specificity often bypassed skepticism.
A week later, another subtle signal. A quiet call from my contact: “Harding just completed an initial sweep of publicly available records for CogniSolve Labs. He confirmed the firm’s existence, its abrupt dissolution, and hints of high-risk neurological research.”
More importantly, my contact confirmed a major part of this twist: “He also noted that a prominent venture capitalist, with no prior biotech experience, was listed as the *primary, secretive investor* in CogniSolve Labs.”
The description was unmistakable. Sera.
This was a major win. Harding was connecting the dots. He wouldn’t know it was Sera yet, but he had confirmed the core elements of the plot: the firm, the dangerous research, and the secretive investor.
The personal cruelty beat here was the subtle confirmation of Sera’s coldness. Her primary concern was to appear legitimate while secretly funding a weaponized biotech firm. Her greed was so profound, she’d invest in something designed to unmake a human being.
I knew Harding was discreet. He wouldn’t connect the dots publicly, not yet. He would build his case meticulously.
This also escalated the stakes. Once the police were involved, even discreetly, the situation became far more volatile. Sera, or rather, the syndicate, might detect the investigation.
My feigned decline was becoming more convincing. I deliberately made minor “errors” in conversation, forgetting a name, misplacing my glasses conspicuously. Small, almost imperceptible signs of “fogginess.”
Sera, of course, noticed. She became even more attentive, even more solicitous.
“Julian, you left your phone in the refrigerator again,” she said one morning, holding it up with a gentle, chiding smile. “You really need to try and focus, darling.”
I rubbed my temples, forcing a frustrated sigh. “My mind just isn’t what it used to be, Sera. All this market stress.”
Her smile was a mask of concern, but her eyes held a spark of hidden satisfaction. She believed her poison was working.
Elena, however, watched me with growing concern. She didn’t like my act, knowing the true implications of my simulated decline.
“Are you truly well, Julian?” she asked one afternoon, when Sera was out. Her voice was low, filled with genuine worry.
“It’s just an act, Elena,” I reassured her, my voice equally soft. “Harding needs to believe there’s something to investigate. And Sera needs to believe her plan is succeeding.”
She wrung her hands. “But to see you… to act so…” She trailed off, unable to voice the horror of what she was witnessing.
“It’s necessary,” I insisted, though it pained me to put her through this. “We need external validation, Elena. Something beyond my word, or your testimony. Something that can’t be dismissed as a ‘delusional episode.'”
She nodded slowly, understanding the grim necessity. Her loyalty was immense, her burden heavy.
Harding’s investigation, though slow and methodical, was crucial. It provided an independent verification of the neurotoxin’s existence and Sera’s involvement. It was a concrete external step that couldn’t be easily undone.
The clock was still ticking on my personal health, but now, a new ally, even an unwitting one, was beginning to move the pieces on the chessboard.
I knew the syndicate, if they truly existed as Evelyn suggested and Finch’s encrypted messages implied, would be watching. They would have feelers everywhere.
Harding’s quiet investigation might soon become a target. I had to accelerate my own efforts.
The confirmation of the neurotoxin and Sera’s secret investment was a vindication, but it also painted a grim picture. I was up against a ruthless, well-funded adversary, one who was willing to deploy untraceable poisons and orchestrate elaborate financial attacks.
I looked at the framed photo of my grandfather and Evelyn, taken when they first founded Maxwell Tech. Their vision, their legacy, was under attack.
I wouldn’t let them down.
More Stories
+ There are no comments
Add yours